Elizabeth Arden (RDEN) Misses Q2 EPS by 31c

Elizabeth Arden (NASDAQ: rden) reported Q2 EPS of $0.28, $0.31 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $333.6 million versus the consensus estimate of $366.5 million.

The Company currently expects the following for the second half of fiscal 2015:

• Net sales increases in the International segment versus the prior year period at constant currency rates with continued declines in celebrity fragrances impacting the North American segment;
• Gross margin expansion due to improved pricing, better sales mix, lower discounts and realization of reduced supply chain and product costs;
• Lower overall selling, general and administrative expenses, with some reinvestment of 2014 Improvement Plan savings to drive future growth;
• Improved EBITDA margins from gross margin expansion and lower selling, general and administrative expenses;
• Stronger cash flow from operations from improved working capital; and
• Consistent with prior expectations, sequential improvement weighted towards the fourth fiscal quarter;

For earnings history and earnings-related data on Elizabeth Arden (rden) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• L3Harris names Sam Mehta CEO after Kubasik exits over conduct issues
• Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord